Dr. Elisabet Manasanch, MD

Dr. Manasanch is an Assistant Professor at the Department of Lymphoma/Myeloma at the University of Texas MD Anderson Cancer Center. She graduated with an MD degree from the University of Barcelona in 2005 and received an MHSc in Clinical Research from Duke University in 2014. She pursued internal medicine and medical oncology training at the University of Massachusetts and National Institutes of Health, respectively and is board-certified in both specialties. During her fellowship training at the National Institutes of Health, Dr. Manasanch focused on the research and treatment of plasma cell dyscrasias. Currently, she leads the myeloma precursor disease program at MD Anderson with a focus in understanding early stages through new technology and applying immunotherapy to early treatment.